UCB/Sanofi’s Xyzal Clears FDA As Once-Daily Antihistamine
This article was originally published in The Pink Sheet Daily
Executive Summary
Xyzal will be available for the fall allergy season after being approved for symptoms associated with seasonal and perennial allergic rhinitis.